Generali Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$987K Sell
4,470
-1,309
-23% -$362K 0.02% 337
2026
Q1
$1.71M Buy
5,779
+2,108
+57% +$626K 0.04% 321
2025
Q4
$1M Sell
3,671
-3,461
-49% -$940K 0.02% 392
2025
Q3
$1.93M Sell
7,132
-418
-6% -$114K 0.04% 317
2025
Q2
$2.08M Buy
7,550
+3,612
+92% +$982K 0.05% 300
2025
Q1
$1.04M Buy
3,938
+413
+12% +$102K 0.03% 384
2024
Q4
$819K Buy
+3,525
New +$811K 0.02% 382

Other funds holding CME

Generali Asset Management's CME Position: Q2 2026 in Review

Generali Asset Management reduced its CME Group (CME) stake by 23% in Q2 2026, selling an estimated $362K and leaving 4,470 shares worth $987K. The position accounts for 0.02% of the portfolio, ranked #337.

Generali Asset Management first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.08M in Q2 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Generali Asset Management held 4,470 shares of CME Group worth $987K as of Q2 2026.
  • Generali Asset Management sold 1,309 CME Group shares in Q2 2026, an estimated $362K.
  • CME Group made up 0.02% of Generali Asset Management's portfolio in Q2 2026, its #337 holding.
  • Generali Asset Management first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's CME Group position peaked at $2.08M in Q2 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.